Aristotle 65 Macrowire
Scientia Vascular · Decision date Sep 16, 2026
What did the FDA decide?
The FDA recorded a substantial equivalence decision, dated 2026-09-16, for Scientia Vascular's Aristotle 65 Macrowire under premarket notification K254181, in the Cardiovascular specialty with product code MOF. The letter describes the device as intended for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters. Substantial equivalence is a clearance, not approval of a premarket approval application.
The excerpts indicate the submission included risk assessments conducted in accordance with ISO 14971:2019 and performance testing on the subject devices, and that the letter restates Quality Management System Regulation obligations, including ISO 13485 design-control and corrective-action clauses. The excerpts do not identify a predicate device, the specific tests or results, or any cleared labeling beyond the stated intended use, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254181
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Scientia Vascular
- Product code
- MOF
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Guide, Wire, Catheter, Neurovasculature.
- Applicant
- Scientia Vascular
- Product code
- MOF
- FDA device class
- 2
FDA decision timeline
K254181 received
Application receipt date recorded by FDA.
K254181 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MOF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
35 Helix GuidewireK260751 | Piraeus Medical, Inc. | 510(k) clearance | Aug 27, 2026 | FDA |
Willow 12 GuidewireK262424 | Arbor Endovascular, LLC | 510(k) clearance | Aug 14, 2026 | FDA |
Aristotle Mini GuidewireK260223 | Scientia Vascular, Inc. | 510(k) clearance | Aug 6, 2026 | FDA |
Drivewire 35 GuidewireK254006 | Rapid-Medical , Ltd. | 510(k) clearance | Jul 17, 2026 | FDA |
| Scientia Vascular, Inc. | 510(k) clearance | Apr 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Scientia Vascular
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- West Valley City, UT
Sources and methodology
- Original FDA record: K254181
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

